ModelEdge

Arca Biopharma Inc.
ABIO
Filing Type8-K
Filing Date9/21/2025
Updated9/22/25, 2:26 PM

Filing

8-K
Earnings Release

Exhibits

8-KMaterial Contracts, Unregistered Sales of Equity Securities, Reg. FD
EX-4.1FORM OF PRE-FUNDED WARRANT
EX-10.1SECURITIES PURCHASE AGREEMENT, DATED SEPTEMBER 17, 2025, BY AND BETWEEN ORUKA THERAPEUTICS, INC. AND EACH PURCHASER IDENTIFIED ON ANNEX A THERETO
EX-10.2FORM OF REGISTRATION RIGHTS AGREEMENT
EX-99.1Material Contracts, Unregistered Sales of Equity Securities, Reg. FD
EX-99.2Material Contracts, Unregistered Sales of Equity Securities, Reg. FD
GRAPHICGraphic
GRAPHICGraphic